Bristol Myers Squibb (BMY) Construction in Progress (2015 - 2026)

Bristol Myers Squibb (BMY) has reported Construction in Progress for 12 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Construction in Progress fell 26.41% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 26.41% decrease from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 6.16% from the prior year.
• Construction in Progress was $1.3 billion for Q2 2026 at Bristol Myers Squibb, down from $1.5 billion in the prior quarter.
• Over five years, Construction in Progress peaked at $1.8 billion in Q2 2025 and troughed at $800.0 million in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress surged 54.14% in 2022 and dropped 26.41% in 2026, its largest moves.
• Over 5 years, Construction in Progress stood at $1.1 billion in 2022, then climbed by 2.09% to $1.1 billion in 2023, then soared by 41.86% to $1.5 billion in 2024, then climbed by 6.16% to $1.6 billion in 2025, then dropped by 19.95% to $1.3 billion in 2026.
• The last three Construction in Progress figures came in at $1.3 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.